These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1112 related articles for article (PubMed ID: 33956050)
1. Asymptomatic and Symptomatic SARS-CoV-2 Infections After BNT162b2 Vaccination in a Routinely Screened Workforce. Tang L; Hijano DR; Gaur AH; Geiger TL; Neufeld EJ; Hoffman JM; Hayden RT JAMA; 2021 Jun; 325(24):2500-2502. PubMed ID: 33956050 [TBL] [Abstract][Full Text] [Related]
2. Asymptomatic SARS-CoV-2 Vaccine Breakthrough Infections in Health Care Workers Identified Through Routine Universal Surveillance Testing. Novazzi F; Taborelli S; Baj A; Focosi D; Maggi F Ann Intern Med; 2021 Dec; 174(12):1770-1772. PubMed ID: 34662153 [No Abstract] [Full Text] [Related]
3. Asymptomatic and Symptomatic COVID-19 Infections Among Health Care Personnel Before and After Vaccination. Gohil SK; Olenslager K; Quan KA; Dastur CK; Afsar N; Chang W; Huang SS JAMA Netw Open; 2021 Jul; 4(7):e2115980. PubMed ID: 34236414 [TBL] [Abstract][Full Text] [Related]
4. Incident SARS-CoV-2 Infection among mRNA-Vaccinated and Unvaccinated Nursing Home Residents. White EM; Yang X; Blackman C; Feifer RA; Gravenstein S; Mor V N Engl J Med; 2021 Jul; 385(5):474-476. PubMed ID: 34010526 [No Abstract] [Full Text] [Related]
5. Mass screening of healthcare personnel for SARS-CoV-2 in the Northern Emirates. Park SS; Oh HY; Hong DJ J Hosp Infect; 2021 Feb; 108():52-54. PubMed ID: 33080317 [No Abstract] [Full Text] [Related]
6. Symptomatic SARS-CoV-2 infections after full schedule BNT162b2 vaccination in seropositive healthcare workers: a case series from a single institution. Baj A; Novazzi F; Genoni A; Ferrante FD; Taborelli S; Pini B; Partenope M; Valli M; Gasperina DD; Capuano R; Prestia M; Spezia PG; Azzi L; Focosi D; Maggi F Emerg Microbes Infect; 2021 Dec; 10(1):1254-1256. PubMed ID: 34110974 [TBL] [Abstract][Full Text] [Related]
8. Immunogenicity of the BNT162b2 COVID-19 mRNA vaccine and early clinical outcomes in patients with haematological malignancies in Lithuania: a national prospective cohort study. Maneikis K; Šablauskas K; Ringelevičiūtė U; Vaitekėnaitė V; Čekauskienė R; Kryžauskaitė L; Naumovas D; Banys V; Pečeliūnas V; Beinortas T; Griškevičius L Lancet Haematol; 2021 Aug; 8(8):e583-e592. PubMed ID: 34224668 [TBL] [Abstract][Full Text] [Related]
9. Assessment of an Online Tool to Simulate the Effect of Pooled Testing for SARS-CoV-2 Detection in Asymptomatic and Symptomatic Populations. Polage CR; Lee MJ; Hubbard C; Rehder C; Cardona D; Denny T; Datto MB JAMA Netw Open; 2020 Dec; 3(12):e2031517. PubMed ID: 33301014 [TBL] [Abstract][Full Text] [Related]
10. Association Between Exposure Characteristics and the Risk for COVID-19 Infection Among Health Care Workers With and Without BNT162b2 Vaccination. Oster Y; Benenson S; Yochi Harpaz L; Buda I; Nir-Paz R; Strahilevitz J; Cohen MJ JAMA Netw Open; 2021 Sep; 4(9):e2125394. PubMed ID: 34468758 [TBL] [Abstract][Full Text] [Related]
11. Early rate reductions of SARS-CoV-2 infection and COVID-19 in BNT162b2 vaccine recipients. Amit S; Regev-Yochay G; Afek A; Kreiss Y; Leshem E Lancet; 2021 Mar; 397(10277):875-877. PubMed ID: 33610193 [No Abstract] [Full Text] [Related]
12. Mass testing for covid-19 in the UK. Gill M; Gray M BMJ; 2020 Nov; 371():m4436. PubMed ID: 33199289 [No Abstract] [Full Text] [Related]
13. Comparison of Upper Respiratory Viral Load Distributions in Asymptomatic and Symptomatic Children Diagnosed with SARS-CoV-2 Infection in Pediatric Hospital Testing Programs. Kociolek LK; Muller WJ; Yee R; Dien Bard J; Brown CA; Revell PA; Wardell H; Savage TJ; Jung S; Dominguez S; Parikh BA; Jerris RC; Kehl SC; Campigotto A; Bender JM; Zheng X; Muscat E; Linam M; Abuogi L; Smith C; Graff K; Hernandez-Leyva A; Williams D; Pollock NR J Clin Microbiol; 2020 Dec; 59(1):. PubMed ID: 33093026 [TBL] [Abstract][Full Text] [Related]
14. Postvaccination SARS-CoV-2 Infections Among Skilled Nursing Facility Residents and Staff Members - Chicago, Illinois, December 2020-March 2021. Teran RA; Walblay KA; Shane EL; Xydis S; Gretsch S; Gagner A; Samala U; Choi H; Zelinski C; Black SR MMWR Morb Mortal Wkly Rep; 2021 Apr; 70(17):632-638. PubMed ID: 33914721 [TBL] [Abstract][Full Text] [Related]
15. Prospective observational study and serosurvey of SARS-CoV-2 infection in asymptomatic healthcare workers at a Canadian tertiary care center. Ferreira VH; Chruscinski A; Kulasingam V; Pugh TJ; Dus T; Wouters B; Oza A; Ierullo M; Ku T; Majchrzak-Kita B; Humar ST; Bahinskaya I; Pinzon N; Zhang J; Heisler LE; Krzyzanowski PM; Lam B; Lungu IM; Manase D; Pace KM; Mashouri P; Brudno M; Garrels M; Mazzulli T; Cybulsky M; Humar A; Kumar D PLoS One; 2021; 16(2):e0247258. PubMed ID: 33592074 [TBL] [Abstract][Full Text] [Related]
16. Assessment of Effectiveness of 1 Dose of BNT162b2 Vaccine for SARS-CoV-2 Infection 13 to 24 Days After Immunization. Chodick G; Tene L; Patalon T; Gazit S; Ben Tov A; Cohen D; Muhsen K JAMA Netw Open; 2021 Jun; 4(6):e2115985. PubMed ID: 34097044 [TBL] [Abstract][Full Text] [Related]
17. Universal screening identifies asymptomatic carriers of SARS-CoV-2 among pregnant women in India. Waghmare R; Gajbhiye R; Mahajan NN; Modi D; Mukherjee S; Mahale SD Eur J Obstet Gynecol Reprod Biol; 2021 Jan; 256():503-505. PubMed ID: 33393481 [No Abstract] [Full Text] [Related]
18. Preoperative Universal SARS-CoV-2 Screening for Asymptomatic Patients: A Report From Tokyo, Japan. Komori A; Mori H; Kojima Y; Tabe Y; Naito T J Cardiothorac Vasc Anesth; 2021 Apr; 35(4):1265-1267. PubMed ID: 33645509 [No Abstract] [Full Text] [Related]
19. Associations of BNT162b2 vaccination with SARS-CoV-2 infection and hospital admission and death with covid-19 in nursing homes and healthcare workers in Catalonia: prospective cohort study. Cabezas C; Coma E; Mora-Fernandez N; Li X; Martinez-Marcos M; Fina F; Fabregas M; Hermosilla E; Jover A; Contel JC; Lejardi Y; Enfedaque B; Argimon JM; Medina-Peralta M; Prieto-Alhambra D BMJ; 2021 Aug; 374():n1868. PubMed ID: 34407952 [TBL] [Abstract][Full Text] [Related]
20. Public health impact of delaying second dose of BNT162b2 or mRNA-1273 covid-19 vaccine: simulation agent based modeling study. Romero-Brufau S; Chopra A; Ryu AJ; Gel E; Raskar R; Kremers W; Anderson KS; Subramanian J; Krishnamurthy B; Singh A; Pasupathy K; Dong Y; O'Horo JC; Wilson WR; Mitchell O; Kingsley TC BMJ; 2021 May; 373():n1087. PubMed ID: 33980718 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]